Free Trial
NASDAQ:TRVN

Trevena (TRVN) Stock Price, News & Analysis

Trevena logo
$0.01 0.00 (-20.00%)
As of 10:56 AM Eastern

About Trevena Stock (NASDAQ:TRVN)

Advanced

Key Stats

Today's Range
$0.0120
$0.0120
50-Day Range
$0.00
$0.91
52-Week Range
$0.00
$4.68
Volume
316 shs
Average Volume
2,125 shs
Market Capitalization
$11.51 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

Trevena Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

TRVN MarketRank™: 

Trevena scored higher than 41% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Trevena has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    Trevena has a consensus price target of $5.00, representing about 41,566.7% upside from its current price of $0.01.

  • Amount of Analyst Coverage

    Trevena has received no research coverage in the past 90 days.

  • Read more about Trevena's stock forecast and price target.
  • Earnings Growth

    Earnings for Trevena are expected to grow in the coming year, from ($23.04) to ($0.90) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Trevena is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Trevena is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Trevena's valuation and earnings.
  • Percentage of Shares Shorted

    0.38% of the outstanding shares of Trevena have been sold short.
  • Short Interest Ratio / Days to Cover

    Trevena has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Trevena has recently decreased by 10.00%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Trevena does not currently pay a dividend.

  • Dividend Growth

    Trevena does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.38% of the outstanding shares of Trevena have been sold short.
  • Short Interest Ratio / Days to Cover

    Trevena has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Trevena has recently decreased by 10.00%, indicating that investor sentiment is improving significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, Trevena insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 2.70% of the stock of Trevena is held by insiders.

    • Percentage Held by Institutions

      Only 13.56% of the stock of Trevena is held by institutions.

    • Read more about Trevena's insider trading history.
    Receive TRVN Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Trevena and its competitors with MarketBeat's FREE daily newsletter.

    By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

    TRVN Stock News Headlines

    Trevena, Inc. (TRVN) - Yahoo Finance
    China’s message to Trump
    Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in his urgent broadcast, he names three investments he believes could soar as America’s financial system nears a breaking point.tc pixel
    JMP Securities downgrades Trevena (TRVN) to a Hold
    Trevena appoints new financial chief
    See More Headlines

    TRVN Stock Analysis - Frequently Asked Questions

    Trevena's stock was trading at $1.50 on January 1st, 2025. Since then, TRVN shares have decreased by 99.2% and is now trading at $0.0120.

    Trevena, Inc. (NASDAQ:TRVN) issued its earnings results on Thursday, August, 8th. The biopharmaceutical company reported ($0.23) EPS for the quarter, beating analysts' consensus estimates of ($9.25) by $9.02. The biopharmaceutical company had revenue of $0.33 million for the quarter.

    Trevena shares reverse split on the morning of Tuesday, August 13th 2024.The 1-25 reverse split was announced on Thursday, August 8th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

    Shares of TRVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Trevena investors own include Novavax (NVAX), Conatus Pharmaceuticals (CNAT), Sorrento Therapeutics (SRNE), NIO (NIO), TherapeuticsMD (TXMD), Cara Therapeutics (CARA) and SCYNEXIS (SCYX).

    Company Calendar

    Last Earnings
    8/08/2024
    Today
    10/02/2025
    Next Earnings (Estimated)
    11/05/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    Pharmaceutical preparations
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:TRVN
    CIK
    1429560
    Fax
    N/A
    Employees
    40
    Year Founded
    2008

    Price Target and Rating

    High Price Target
    $5.00
    Low Price Target
    $5.00
    Potential Upside/Downside
    +41,566.7%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    1 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    ($47.04)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$40.29 million
    Net Margins
    N/A
    Pretax Margin
    -6,222.30%
    Return on Equity
    N/A
    Return on Assets
    -119.55%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    2.42
    Quick Ratio
    2.42

    Sales & Book Value

    Annual Sales
    $443 thousand
    Price / Sales
    0.03
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    ($11.07) per share
    Price / Book
    0.00

    Miscellaneous

    Outstanding Shares
    959,000
    Free Float
    841,000
    Market Cap
    $11.51 thousand
    Optionable
    Optionable
    Beta
    0.45

    Social Links

    Beginner's Guide To Retirement Stocks Cover

    Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

    Get This Free Report

    This page (NASDAQ:TRVN) was last updated on 10/2/2025 by MarketBeat.com Staff
    From Our Partners